Strategies Aimed at Nox4 Oxidase Inhibition Employing Peptides from Nox4 B-Loop and C-Terminus and p22phox N-Terminus: An Elusive Target
Although NADPH oxidase 4 (Nox4) is the most abundant Nox isoform in systemic vascular endothelial and smooth muscle cells, its function in the vascular tissue is not entirely known. The literature describes a pathophysiological role for Nox4 in cardiovascular disease; however, some studies have repo...
Main Authors: | Gábor Csányi, Patrick J. Pagano |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2013-01-01
|
Series: | International Journal of Hypertension |
Online Access: | http://dx.doi.org/10.1155/2013/842827 |
Similar Items
-
CRISPR/Cas9-mediated knockout of p22phox leads to loss of Nox1 and Nox4, but not Nox5 activity
by: Kim-Kristin Prior, et al.
Published: (2016-10-01) -
NOX, NOX who is there?, The contribution of NADPH Oxidase to beta cell dysfunction.
by: David eTaylor-Fishwick
Published: (2013-04-01) -
NADPH oxidase 4 (Nox4) deletion accelerates liver regeneration in mice
by: M. Herranz-Itúrbide, et al.
Published: (2021-04-01) -
Solid Phase Formylation of N-Terminus Peptides
by: Anna Lucia Tornesello, et al.
Published: (2016-06-01) -
Identification of Small Peptides that Inhibit NADPH Oxidase (Nox2) Activation
by: Aron B. Fisher, et al.
Published: (2018-12-01)